Suppliers / Meyer Bpc Joint Venture

Meyer Bpc Joint Venture

Vietnam Updated 9 July 2026

Meyer Bpc Joint Venture is an API and finished-dose manufacturer based in Vietnam. It appears in 586 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam) and DH (HK).

0
active US DMFs
0
valid CEPs
0
registered plants
586
filings across 2 regulators

What they file, and where

Molecule Regulators Docs
Hydroclorothiazide DAV (Vietnam) 5
Aluminum Hydroxide DAV (Vietnam) 3
Ambroxol DAV (Vietnam) 3
Febuxostat DAV (Vietnam) 3
Fexofenadine DAV (Vietnam) 3
Levetiracetam DAV (Vietnam) 3
Piracetam DAV (Vietnam) 3
Acetaminophen DAV (Vietnam) 2
Acetylcysteine DAV (Vietnam) 2
Alverine DAV (Vietnam) 2
Show all 30 molecules on file
Atorvastatin DAV (Vietnam) 2
Baclofen DAV (Vietnam) 2
Betamethasone DAV (Vietnam) 2
Candesartan DAV (Vietnam) 2
Chlorpheniramine DAV (Vietnam) 2
Cholecalciferol DAV (Vietnam) 2
Clindamycin DAV (Vietnam) 2
Clotrimazole DAV (Vietnam) 2
Desloratadine DAV (Vietnam) 2
Entecavir DAV (Vietnam) 2
Fenticonazole DAV (Vietnam) 2
Finasteride DAV (Vietnam) 2
Irbesartan DAV (Vietnam) 2
Ivermectin DAV (Vietnam) 2
Lamivudine DAV (Vietnam) 2
Levosulpiride DAV (Vietnam) 2
Pyridoxine DAV (Vietnam) 2
Sildenafil DAV (Vietnam) 2
Sitagliptin DAV (Vietnam) 2
Sucralfate DAV (Vietnam) 2

Also appears on these molecule pages

Acetylcysteine API Acetylsalicylic Acid API Alverine API Ambroxol API Baclofen API Bambuterol finished dose Betahistine API Bezafibrate API Bromhexine API Canagliflozin finished dose Candesartan API Chlorphenamine API
Show 50 more molecule pages
Chlorpheniramine API Clenbuterol API Clindamycin API Clotrimazole API Cobalamin API Deferiprone finished dose Desloratadine API Dexamethasone API Dexibuprofen API Dexketoprofen API Dextromethorphan API Digoxin API Dimenhydrinate API Entecavir API Febuxostat API Fexofenadine API Finasteride API Flavoxate API Flurbiprofen API Fosfomycin API Hydroclorothiazide API Ivermectin API Lipoic Acid API Lopinavir finished dose Lornoxicam API Loxoprofen finished dose Methocarbamol API Miconazole API Mirtazapine API Naproxen API Nebivolol API Neomycin API Nevirapine API Paroxetine API Piracetam API Pravastatin API Prednisolone API Rebamipid finished dose Repaglinide API Rupatadine API Sucralfate API Zidovudine API Paracetamol API Atorvastatin API Betamethasone API Sitagliptin API Lamivudine API Sildenafil API Levetiracetam API Irbesartan API

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 583 None
DH (HK) 3 None

Questions about Meyer Bpc Joint Venture

Does Meyer Bpc Joint Venture hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Meyer Bpc Joint Venture. It does have 586 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
What does Meyer Bpc Joint Venture make?
30 molecules are on record against Meyer Bpc Joint Venture, including Hydroclorothiazide, Aluminum Hydroxide, Ambroxol and Febuxostat. Each links through to that molecule's full manufacturer list.
Where does Meyer Bpc Joint Venture file?
Filings are on record with DAV (Vietnam) and DH (HK), 586 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Meyer Bpc Joint Venture comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Apitoria Pharma shares 14 molecules Hetero shares 10 molecules Matrix Pharmacorp shares 9 molecules Imexpharm shares 8 molecules Zydus Lifesciences shares 7 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability